Refractory pneumothorax
Conditions
Interventions
Experimental group:Bronchial blocking technique+Bronchial navigation equipment
Control group (self-control):Bronchial blocking technique
Sponsors
The Second Affiliated hospital of Fujian Medical University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Male or female, aged >=18 years old; 2. Patients with various types of pneumothorax with persistent air leakage after 7 days of continuous intercostal drainage; 3. The investigator evaluated that the subject is eligible for bronchial occlusion to treat refractory pneumothorax, and the responsible drainage bronchus can be identified via the blocking balloon; 4. Those whose chest CT shows incomplete interlobar fissures and whose drainage bronchi cannot be located by balloon exploration; 5.Voluntarily participate in the trial and sign the informed consent form;
Exclusion criteria
Exclusion criteria: 1. Contraindications for bronchoscopy: • Myocardial infarction within the past 1 month; • Active massive hemoptysis; Platelet count < 20×109/L; Female patients who are breastfeeding, pregnant or preparing for pregnancy; Malignant arrhythmia, unstable angina pectoris, severe cardiopulmonary insufficiency, hypertensive crisis, severe pulmonary hypertension, intracranial hypertension, acute cerebrovascular events, aortic dissection, aortic aneurysm, severe mental illness and extreme systemic failure, etc; 2.The presence of uncontrolled acute pulmonary infection or severe chronic infection at the target occlusion site; 3.Patients presenting with significant hemodynamic instability or uncontrolled respiratory failure; 4. Those who have undergone incomplete interlobar fissure closure but still have balloon occlusion and the responsible drainage bronchus cannot be determined; 5. Patients with electromagnetic active implant devices in their bodies; 6. Participants are allergic to anesthetics; Or have a history of multiple severe allergies or hereditary allergies; 7. Those who have participated in or are currently participating in drug clinical trials within 3 months prior to the screening, or have participated in other medical device clinical trials within 30 days; 8. The researchers believe that the patient has other circumstances that make them unsuitable for inclusion in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The success rate of incomplete interlobular fissure closure;The cure rate of bronchial occlusion after interlobar fissure closure; | — |
Secondary
| Measure | Time frame |
|---|---|
| Thoracic drainage tube removal rate; | — |
Countries
China
Contacts
Public ContactYiming Zeng
The Second Affiliated hospital of Fujian Medical University
Outcome results
None listed